Skip to search form
Skip to main content
>
Semantic Scholar
Semantic Scholar's Logo
Search
Sign In
Create Free Account
You are currently offline. Some features of the site may not work correctly.
indanocine
Known as:
indanosine
National Institutes of Health
Create Alert
Related topics
Related topics
1 relation
Broader (1)
Indans
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Interaction of microtubule depolymerizing agent indanocine with different human αβ tubulin isotypes
Bajarang Vasant Kumbhar
,
D. Panda
,
Ambarish Kunwar
PloS one
2018
Corpus ID: 4381382
Tubulin isotypes are known to regulate the stability and dynamics of microtubules, and are also involved in the development of…
Expand
2013
2013
Design, synthesis and antiproliferative activity of indole analogues of indanocine
Gemma A. Tunbridge
,
Joseph Oram
,
Lorenzo Caggiano
2013
Corpus ID: 83901515
The design and synthesis of a novel series of indole-analogues of indanocine is reported, together with their antiproliferative…
Expand
2012
2012
Kinetic stabilization of microtubule dynamics by indanocine perturbs EB1 localization, induces defects in cell polarity and inhibits migration of MDA-MB-231 cells.
S. Kapoor
,
D. Panda
Biochemical pharmacology
2012
Corpus ID: 23977147
Cell motility is an essential aspect of metastatic spread of cancer. Microtubule-targeted agents exhibit anti-metastatic…
Expand
2009
2009
Binding of indanocine to the colchicine site on tubulin promotes fluorescence, and its binding parameters resemble those of the colchicine analogue AC.
L. Das
,
S. Gupta
,
D. Dasgupta
,
A. Poddar
,
Mark E. Janik
,
B. Bhattacharyya
Biochemistry
2009
Corpus ID: 22556137
Indanocine, a synthetic indanone, has shown potential antiproliferative activity against several tumor types. It is different…
Expand
2001
2001
Biochemical genetic analysis of indanocine resistance in human leukemia.
X. H. Hua
,
D. Genini
,
+5 authors
L. Leoni
Cancer research
2001
Corpus ID: 17503632
Indanocine is a potent tubulin-binding drug that is cytotoxic to multidrug-resistant cancer cell lines. We demonstrated that…
Expand
2001
2001
Mechanism of Action of Substituted Indanones in Multidrug Resistant Breast Cancer
L. Leoni
2001
Corpus ID: 70620285
Abstract : Mechanism of Action of Substituted Indanones in Multidrug Resistant Breast Cancer Our laboratory has recently…
Expand
Highly Cited
2000
Highly Cited
2000
Indanocine, a microtubule-binding indanone and a selective inducer of apoptosis in multidrug-resistant cancer cells.
L. Leoni
,
E. Hamel
,
+4 authors
D. Carson
Journal of the National Cancer Institute
2000
Corpus ID: 35052942
BACKGROUND Certain antimitotic drugs have antitumor activities that apparently result from interactions with nontubulin…
Expand
Highly Cited
2000
Highly Cited
2000
Tubulin/microtubules: still a promising target for new chemotherapeutic agents.
Paraskevi Giannakakou
,
D. Sackett
,
T. Fojo
Journal of the National Cancer Institute
2000
Corpus ID: 6884648
Most investigators would agree that the ideal chemotherapeutic agent should be 1) directed at a validated target; 2) potent…
Expand
2000
2000
Tubulin as a target for anticancer drugs.
E. von Angerer
Current opinion in drug discovery & development
2000
Corpus ID: 23591981
Nature provides a large spectrum of agents that either inhibit the polymerization of tubulin or prevent the disassembly of…
Expand
2000
2000
Understanding apoptosis involved in the development and treatment of malignancies
D. Genini
2000
Corpus ID: 82557174
Apoptosis is a key event occurring in living organisms. In order to maintain tissue homeostasis, a comparable number of cells…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
,
Terms of Service
, and
Dataset License
ACCEPT & CONTINUE